Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

18.8K
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.8K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

3.9K
3.9K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

3.4K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.4K
Models of Health Promotion and Illness Prevention II01:18

Models of Health Promotion and Illness Prevention II

2.1K
The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results...
2.1K
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

14.6K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
14.6K
Models of Health Promotion and Illness Prevention I01:25

Models of Health Promotion and Illness Prevention I

2.8K
A model is a theoretical way to understand a concept or an idea. Models can overcome barriers to health regardless of diverse economic and cultural backgrounds. In addition, models make the task easier by providing different ways to approach complex issues. There are two major health promotion models: the health belief model and the health promotion model.
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Should flow cytometry be required for CMML diagnosis? Position of the ELN iMDS Flow Working Group.

HemaSphere·2026
Same author

Comprehensive lincRNA Transcriptome in Acute Myeloid Leukemia: Integrating Known and Newly Identified lincRNAs Across Pediatric and Adult Cohorts.

Non-coding RNA·2026
Same author

Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS).

HemaSphere·2026
Same author

Sustained PRC1.1 activity preserves gene repression independently of PRC2.2 and restrains leukemic cell differentiation.

Nucleic acids research·2026
Same author

Prognostic value of measurable residual disease in high-risk MDS after intensive chemotherapy in HOVON-SAKK studies.

HemaSphere·2026
Same author

The oncogenic ΔNp73 isoform contributes to aggressiveness in acute promyelocytic leukemia.

Haematologica·2026

Related Experiment Video

Updated: Feb 4, 2026

Direct Lineage Reprogramming of Adult Mouse Fibroblast to Erythroid Progenitors
11:46

Direct Lineage Reprogramming of Adult Mouse Fibroblast to Erythroid Progenitors

Published on: December 14, 2018

6.9K

TCF4 promotes erythroid development.

Florentien E M In 't Hout1, Jolanda van Duren1, Davide Monteferrario1

  • 1Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Centre, Nijmegen, The Netherlands.

Experimental Hematology
|October 14, 2018
PubMed
Summary
This summary is machine-generated.

Transcription factor 4 (TCF4) promotes erythroid development and is downregulated in myelodysplastic syndrome (MDS). Lower TCF4 levels in MDS patients correlate with reduced hemoglobin, highlighting TCF4

More Related Videos

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.8K
Plant Promoter Analysis: Identification and Characterization of Root Nodule Specific Promoter in the Common Bean
10:58

Plant Promoter Analysis: Identification and Characterization of Root Nodule Specific Promoter in the Common Bean

Published on: December 23, 2017

13.0K

Related Experiment Videos

Last Updated: Feb 4, 2026

Direct Lineage Reprogramming of Adult Mouse Fibroblast to Erythroid Progenitors
11:46

Direct Lineage Reprogramming of Adult Mouse Fibroblast to Erythroid Progenitors

Published on: December 14, 2018

6.9K
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.8K
Plant Promoter Analysis: Identification and Characterization of Root Nodule Specific Promoter in the Common Bean
10:58

Plant Promoter Analysis: Identification and Characterization of Root Nodule Specific Promoter in the Common Bean

Published on: December 23, 2017

13.0K

Area of Science:

  • Hematology
  • Molecular Biology
  • Cell Differentiation

Background:

  • Transcription factor 4 (TCF4) is known to be involved in lymphoid cell differentiation.
  • TCF4 expression levels are a predictive factor for outcomes in acute myeloid leukemia.
  • The role of TCF4 in myelopoiesis, particularly in erythroid and megakaryocytic differentiation, requires further investigation.

Purpose of the Study:

  • To investigate the function of Transcription factor 4 (TCF4) in the process of myelopoiesis.
  • To determine the impact of TCF4 on erythroid and megakaryocytic progenitor cells.
  • To examine the role of TCF4 in myelodysplastic syndrome (MDS), a disorder affecting myeloid cell development.

Main Methods:

  • Overexpression (OE) and knockdown (KD) of TCF4 in umbilical cord blood (UCB) cells.
  • Assessment of colony-forming units for erythroid (CFU-Es) and megakaryocytes (CFU-MKs).
  • Analysis of TCF4 mRNA expression in hematopoietic stem cells and progenitor populations from MDS patients and healthy controls.

Main Results:

  • TCF4 overexpression increased erythroid colony formation, while knockdown significantly decreased it.
  • Both TCF4 knockdown and overexpression inhibited megakaryocyte colony formation.
  • TCF4 expression was lower in erythroid-lineage progenitors from MDS patients compared to healthy controls, correlating with lower hemoglobin levels.

Conclusions:

  • TCF4 plays a significant role in promoting erythroid differentiation.
  • TCF4 is implicated in megakaryocytic differentiation, with both increased and decreased expression affecting colony formation.
  • Reduced TCF4 expression in MDS patients contributes to impaired erythropoiesis and lower hemoglobin levels, suggesting TCF4 as a novel factor in erythroid-megakaryocytic development.